Navigation Links
Court Grants Preliminary Approval to Class Action Settlement that Provides Benefits Of Approximately $20 Million to Healthcare Providers that Purchased a SS1 Before January 1, 2009

HAVERFORD, Pa., March 4, 2011 /PRNewswire-USNewswire/ -- On March 3, 2011, the United States District Court for the Northern District of Ohio granted preliminary approval to a proposed settlement reached in a class action lawsuit filed by Chimicles & Tikellis LLP ("C&T") against STERIS Corporation ("STERIS").  The lawsuit is related to STERIS' marketing and sale of the STERIS SYSTEM 1® Sterile Processor (the "SS1 Device"), a tabletop liquid chemical system that provides rapid, low-temperature processing of surgical instruments such as endoscopes and bronchoscopes.  

Sterilization systems like the SS1 Device must be cleared by the FDA before they can be sold to healthcare providers.  The FDA cleared the SS1 in 1988.  The lawsuit filed by C&T alleges that STERIS made several material changes to the SS1 Device after 1988 without obtaining the necessary clearance from the FDA, and that as a result, the FDA informed healthcare providers that use of the SS1 Device "should be discontinued as soon as practicable," but no later than August 2, 2011.  STERIS subsequently entered into a consent decree with the FDA to implement a transition plan whereby healthcare providers could return their SS1 Devices to STERIS in exchange for a rebate (the "Rebate Program").  There are no allegations in this case that the SS1 Devices create a safety hazard, nor that anyone has been harmed as a result of using the SS1 Devices.

The proposed settlement of the class action lawsuit is on behalf of all domestic healthcare providers that own or owned a SS1 Device that was (a) purchased before January 1, 2009, and (b) in use on December 1, 2009.  SS1 Devices purchased after January 1, 2009 are not part of this proposed settlement because they are already eligible for a full refund from STERIS under the Rebate Program.  In December 2009, STERIS prepared a list of SS1 Devices then in use -- the "Transition List."  All eligible healthcare providers on the Transition List will be sent notice of the settlement.  The settlement applies to approximately 20,000 SS1 Devices owned by approximately 6,600 customers.   Based on the number of Eligible SS1 Devices and settlement options made available to each, C&T estimates that the settlement provides approximately $20 million of benefits to the class.  

The benefits that class members can elect to receive differs depending on whether they are members of Sub-Class A, Sub-Class B, or Sub-Class C:  Sub-ClassDescription

Settlement ConsiderationA

Class Members that (a) purchased or elect to purchase SYSTEM 1E™  ("SS1E") Device from STERIS on or before December 31, 2012, and (b) either (i) still have the Eligible SS1 Device(s) or (ii) returned the Eligible SS1 Device(s) to STERIS in the Rebate Program.  The SS1E is STERIS' next generation liquid chemical sterilant processing system.

Will receive SS1E Credits in the amount of $1,000.00 per Eligible SS1 Device, which can be applied towards the purchase of any SS1E Accessories, Parts Or Consumables; SS1E credits can be combined, and must be claimed by December 31, 2012.Class Members that (a) do not elect to purchase an SS1E Device and (b) either (i) still have the Eligible SS1 Device(s) or (ii) returned the Eligible SS1 Device(s) to STERIS in the Rebate Program.

Will, for each Eligible SS1 Device, have the option to receive either (a) $500 in STERIS Product Credits, or (b) $300.00 in cash.  STERIS Product Credits may be redeemed for any STERIS product(s) other than an SS1E Device, service, or service contracts.  STERIS Product Credits can be combined and must be claimed by December 31, 2012. C

Class Members that, for any reason other than because the Eligible SS1 Device was returned to STERIS in the Rebate Program, no longer have the Eligible SS1 Device.

Will be entitled to receive a $200.00 cash payment from STERIS for each Eligible SS1 Device.   In order to receive this settlement consideration, the Court must grant final approval of this settlement and all Class Members (except for those in Sub-Class C) will be required to return their Eligible SS1 Units to STERIS.  Class Members will also be required to return to STERIS all open or used SS1 quick connects, parts, trays, containers, filters, sterility assurance products, S20 sterilant, and other parts, accessories, or consumables for their SS1 Devices that are in the Class Member's possession.  If Class Members have already disposed of these open or used items, they will be given the option to sign a certification confirming that these items have been disposed of and are no longer useable.  

Class members will be mailed a claim form within ten days after the Court grants final approval to the settlement.  The Court will hold a hearing to decide whether to grant final approval to the settlement on June 6, 2011 at 2:00 p.m.  Class members will then have until December 31, 2012 to return their claim form to the address listed on the claim form.  

For additional information about the settlement, you may contact the attorneys below, or visit the settlement website, which will be activated shortly:  

Attorneys to Contact: Nicholas E. Chimicles ( Joseph G. Sauder ( F. Johns ( West Lancaster Avenue, Haverford, PA 19041 Phone:

SOURCE Chimicles & Tikellis LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. German High Court Rules in Favor of AmniSure® as New European Guidelines Published
2. US Supreme Court Denies Certiorari and Thereby Leaves in Place Second Circuit Ruling That Novartis Pharmaceuticals Corporation Must Pay its Sales Representatives Overtime Compensation
3. Court of Appeals Overturns $1.8 Billion Patent Verdict for Centocor Ortho Biotech Inc.
4. Final Superior Court Ruling on Trade Secret Lawsuit Favors Volcano Corporation and Its Axsun Subsidiary
5. Watson Announces Favorable District Court Ruling in Generic Mucinex® Patent Suit
6. Massachusetts Court Rules in Favor of Volcano and Against St. Jude Medical Subsidiary in Trade Secrets Case
7. Sensipar® Patents Upheld By District Court
8. U.S. District Court Rules from Bench in Lillys Favor, Confirms Validity of Alimta Patent
9. Occlutech Wins Dutch Appeal Court Ruling Against AGA Medical
10. Mylan to Appeal Court Decision in Generic Paroxetine Hydrochloride CR Case
11. Statement of Ben Anderson, Esq., Regarding Denial of Wyeths En Banc Petition to Sixth Circuit Court of Appeals in Major Drug Regulation Pre-emption Case
Post Your Comments:
(Date:10/13/2015)... 2015  Data Science Automation (DSA), a system integration and ... branch office in the United Kingdom ... Europe . The decision to open the new ... support of customers in the medical device industry throughout the ... Manager. "We have had tremendous success over the last several ...
(Date:10/13/2015)... 13, 2015  Nanomedical Diagnostics, a biotech company ... and diagnostics, announces the completion of a Series ... Serra Ventures. --> ... easy-to-use monitoring and diagnostic platforms that empower individuals ... round will enable the company to commercially release ...
(Date:10/13/2015)... , Oct. 13, 2015 Attracting mid- to large-sized ... key to growing Baltimore into a ... today by the Maryland Technology Enterprise Institute (Mtech) . ... the pieces in place to support innovation hubs and a ... of Mtech Baltimore. "This study is important because we believe ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... ... America (MOAA) will hold its 2015 annual meeting and corresponding ... military career fair; informational seminars; a luncheon featuring keynote speaker ... Chiefs of Staff; and the Community Heroes Award Night, which ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... new Pillars of Excellence in the Life Sciences Initiative aimed at enhancing Purdue’s ... recently announced $2 billion “Ever True” capital campaign. , The investment will result ...
(Date:10/13/2015)... ... October 13, 2015 , ... Sir Grout of Greater ... the local Boston chapter of Ronald McDonald House Charities® (RMHC®). This donation was made ... Sir Grout of Greater Boston since its inception. , “We believe strongly in the ...
(Date:10/13/2015)... Angeles, CA (PRWEB) , ... October 13, 2015 ... ... growing natural beverage companies in the United States, today announced the release of ... Brew Coffee, and new Cranberry Cocktail Agua Fresca. All feature the unique flavor ...
(Date:10/13/2015)... Angeles, CA (PRWEB) , ... October 13, 2015 , ... ... Managed Care, a recent study has shown that women who successfully lose weight with ... women in the United States each year. The article notes that anywhere from 40 ...
Breaking Medicine News(10 mins):